Related Experiment Video
Updated: Jun 11, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
Maria Felicia Faienza1, Ilaria Farella2, Mohamad Khalil2
1Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), Medical School, University of Bari "Aldo Moro", 70124 Bari, Italy.
Insights
Childhood obesity is rising, increasing risks for type 2 diabetes mellitus (T2DM) and metabolic-associated steatotic liver disease (MASLD). Integrating MRI can improve diagnosis in at-risk children.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Hepatology
Background:
- Childhood obesity rates have surged globally, impacting over 340 million children.
- This rise is linked to metabolic disorders like insulin resistance, type 2 diabetes mellitus (T2DM), and metabolic-associated steatotic liver disease (MASLD).
- Nomenclature for hepatic steatosis has evolved from non-alcoholic fatty liver disease (NAFLD) to MASLD.
Purpose of the Study:
- To review the escalation of childhood obesity and the evolving nomenclature of hepatic steatosis (NAFLD to MASLD).
- To emphasize the critical role of pediatric endocrinologists in diagnosing MASLD in children with T2DM.
- To highlight diagnostic inadequacies and propose improved screening strategies.
Main Methods:
- Comprehensive literature review on childhood obesity, T2DM, and MASLD.
- Analysis of current diagnostic challenges and screening limitations.
- Proposal for integrating hepatic magnetic resonance imaging (MRI) into diagnostic protocols.
Main Results:
- Childhood obesity, T2DM, and MASLD are interconnected and escalating health concerns.
- Existing screening and diagnostic methods for MASLD in pediatric T2DM populations are insufficient.
- Hepatic MRI offers a promising complementary tool for enhanced diagnostic precision.
Conclusions:
- A paradigm shift in diagnosing MASLD in pediatric T2DM is necessary.
- Integrating hepatic MRI alongside conventional testing can improve diagnostic accuracy.
- This holistic approach is vital for better outcomes in high-risk children.
Abstract:
In the past thirty years, childhood obesity rates have risen significantly worldwide, affecting over 340 million children in affluent nations. This surge is intricately tied to metabolic disorders, notably insulin resistance, type 2 diabetes mellitus (T2DM), and the continually evolving spectrum of metabolic-associated (dysfunction) steatotic liver disease (MASLD). This review underscores the alarming escalation of childhood obesity and delves comprehensively into the evolving and dynamic changes of nomenclature surrounding diverse conditions of hepatic steatosis, from the initial recognition of non-alcoholic fatty liver disease (NAFLD) to the progressive evolution into MASLD. Moreover, it emphasizes the crucial role of pediatric endocrinologists in thoroughly and accurately investigating MASLD onset in children with T2DM, where each condition influences and exacerbates the progression of the other. This review critically highlights the inadequacies of current screening strategies and diagnosis, stressing the need for a paradigm shift. A proposed solution involves the integration of hepatic magnetic resonance imaging assessment into the diagnostic arsenal for children showing insufficient glycemic control and weight loss post-T2DM diagnosis, thereby complementing conventional liver enzyme testing. This holistic approach aims to significantly enhance diagnostic precision, fostering improved outcomes in this vulnerable high-risk pediatric population.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes: Symptoms, Diagnosis, and Complications
Inborn Errors of Metabolism
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

